Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.1K Hold
19,000
﹤0.01% 1132
2026
Q1
$34.4K Buy
+19,000
New +$32.9K ﹤0.01% 1073
2023
Q2
Sell
-29,296
Closed -$25K 1016
2023
Q1
$25K Buy
+29,296
New +$31.9K ﹤0.01% 937
2021
Q1
Sell
-164,402
Closed -$301K 1427
2020
Q4
$301K Sell
164,402
-207,685
-56% -$100K 0.02% 1045
2020
Q3
$115K Buy
372,087
+189,480
+104% +$72.6K ﹤0.01% 1394
2020
Q2
$40K Buy
+182,607
New +$54.9K ﹤0.01% 1422

Other funds holding OCGN

Winton Group's OCGN Position: Q2 2026 in Review

Winton Group held its Ocugen (OCGN) position steady in Q2 2026 at 19,000 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Winton Group first reported a position in OCGN in Q2 2020 and has held it in 6 quarters since. The position peaked at $301K in Q4 2020. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Winton Group held 19,000 shares of Ocugen worth $29.1K as of Q2 2026.
  • Winton Group left its Ocugen share count unchanged in Q2 2026.
  • Ocugen made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1132 holding.
  • Winton Group first reported a position in Ocugen in Q2 2020 and has held it in 6 quarters since.
  • Winton Group's Ocugen position peaked at $301K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.